BIO Operating Cycle from 2010 to 2026
| BKYI Stock | USD 0.59 0.02 3.28% |
Operating Cycle | First Reported 2010-12-31 | Previous Quarter 171.15 | Current Value 162.6 | Quarterly Volatility 623.81243116 |
Check BIO Key financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BIO Key's main balance sheet or income statement drivers, such as Depreciation And Amortization of 597.6 K, Interest Expense of 256.3 K or Selling General Administrative of 5.2 M, as well as many indicators such as Price To Sales Ratio of 1.04, Dividend Yield of 0.0507 or PTB Ratio of 1.66. BIO financial statements analysis is a perfect complement when working with BIO Key Valuation or Volatility modules.
BIO | Operating Cycle | Build AI portfolio with BIO Stock |
The Operating Cycle trend for BIO Key International offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether BIO Key is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest BIO Key's Operating Cycle Growth Pattern
Below is the plot of the Operating Cycle of BIO Key International over the last few years. It is BIO Key's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BIO Key's overall financial position and show how it may be relating to other accounts over time.
| Operating Cycle | 10 Years Trend |
|
Operating Cycle |
| Timeline |
BIO Operating Cycle Regression Statistics
| Arithmetic Mean | 406.07 | |
| Geometric Mean | 212.39 | |
| Coefficient Of Variation | 153.62 | |
| Mean Deviation | 384.32 | |
| Median | 171.15 | |
| Standard Deviation | 623.81 | |
| Sample Variance | 389,142 | |
| Range | 2.5K | |
| R-Value | (0.26) | |
| Mean Square Error | 386,790 | |
| R-Squared | 0.07 | |
| Significance | 0.31 | |
| Slope | (32.25) | |
| Total Sum of Squares | 6.2M |
BIO Operating Cycle History
About BIO Key Financial Statements
Investors use fundamental indicators, such as BIO Key's Operating Cycle, to determine how well the company is positioned to perform in the future. Although BIO Key's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Operating Cycle | 171.15 | 162.60 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of BIO Key Correlation against competitors. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is there potential for Systems Software market expansion? Will BIO introduce new products? Factors like these will boost the valuation of BIO Key. Projected growth potential of BIO fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about BIO Key listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.90) | Revenue Per Share | Quarterly Revenue Growth (0.28) | Return On Assets | Return On Equity |
The market value of BIO Key International is measured differently than its book value, which is the value of BIO that is recorded on the company's balance sheet. Investors also form their own opinion of BIO Key's value that differs from its market value or its book value, called intrinsic value, which is BIO Key's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because BIO Key's market value can be influenced by many factors that don't directly affect BIO Key's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between BIO Key's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding BIO Key should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, BIO Key's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.